RAZOBIN Powder for solution for injection/infusion Ref.[115313] Active ingredients: Piperacillin Tazobactam

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2024  Publisher: Aurogen South Africa (Pty) Ltd, Woodhill Office Park, Building 1, 53 Phillip Engelbrecht Avenue, Meyersdal, Ext. 12, 1448, Johannesburg, South Africa

Product name and form

RAZOBIN 2 (Lyophilised powder for solution for injection/infusion).

RAZOBIN 3 (Lyophilised powder for solution for injection/infusion).

RAZOBIN 4 (Lyophilised powder for solution for injection/infusion).

Pharmaceutical Form

A white to off-white cryodessicated powder. When reconstituted, a light yellow coloured, clear solution free from visible particulate matter is formed.

Qualitative and quantitative composition

RAZOBIN 2: Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for solution for injection/infusion equivalent to piperacillin 2,0 g and tazobactam 0,25 g. Each vial contains 4, 7 milli-equivalents (108 mg) of sodium.

RAZOBIN 3: Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for solution for injection/infusion equivalent to piperacillin 3,0 g and tazobactam 0,375 g. Each vial contains 7, 05 milli-equivalents (162 mg) of sodium.

RAZOBIN 4: Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for solution for injection/infusion equivalent to piperacillin 4,0 g and tazobactam 0,5 g. Each vial contains 9, 40 milli-equivalents (216 mg) of sodium.

Active Ingredient

Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.

List of Excipients

Pack sizes and marketing

RAZOBIN 2

30 mL clear, colourless, tubular glass vials fitted with 20 mm grey colour bromo butyl rubber stoppers and sealed with 20 mm aluminium seal with a violet coloured PP disc.

Pack size: Single vial packed in printed carton with a package insert. Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for injection equivalent to piperacillin 2,0 g and tazobactam 0,25 g.

RAZOBIN 3

30 mL clear, colourless, tubular glass vials fitted with 20 mm grey colour bromo butyl rubber stoppers and sealed with 20 mm aluminium seal with a light blue coloured PP disc.

Pack size: Single vial packed in printed carton with a package insert. Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for injection equivalent to piperacillin 3,0 g and tazobactam 0,375 g.

RAZOBIN 4

48 mL clear, colourless, tubular glass vials fitted with 20 mm grey colour bromo butyl rubber stoppers and sealed with 20 mm aluminium seal with a red coloured PP disc.

Pack size: Single vial packed in printed carton with a package insert. Each vial contains piperacillin sodium and tazobactam sodium cryodessicated powder for injection equivalent to piperacillin 4,0 g and tazobactam 0,5 g.

Marketing authorization holder

Aurogen South Africa (Pty) Ltd, Woodhill Office Park, Building 1, 53 Phillip Engelbrecht Avenue, Meyersdal, Ext. 12, 1448, Johannesburg, South Africa

Marketing authorization dates and numbers

RAZOBIN 2: 44/20.1.1/0080
RAZOBIN 3: 44/20.1.1/0081
RAZOBIN 4: 44/20.1.1/0082

Drugs

Drug Countries
RAZOBIN South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.